The Access Technology Program of the Indiana Clinical Translational Sciences Institute (CTSI): A model to facilitate access to cutting-edge technologies across a state.
CTSI
Translational research
core facilities
pilot funding
technology
Journal
Journal of clinical and translational science
ISSN: 2059-8661
Titre abrégé: J Clin Transl Sci
Pays: England
ID NLM: 101689953
Informations de publication
Date de publication:
19 Aug 2020
19 Aug 2020
Historique:
entrez:
5
5
2021
pubmed:
6
5
2021
medline:
6
5
2021
Statut:
epublish
Résumé
Access to cutting-edge technologies is essential for investigators to advance translational research. The Indiana Clinical and Translational Sciences Institute (CTSI) spans three major and preeminent universities, four large academic campuses across the state of Indiana, and is mandate to provide best practices to a whole state. To address the need to facilitate the availability of innovative technologies to its investigators, the Indiana CTSI implemented the Access Technology Program (ATP). The activities of the ATP, or any program of the Indiana CTSI, are challenged to connect technologies and investigators on the multiple Indiana CTSI campuses by the geographical distances between campuses (1-4 hr driving time). Herein, we describe the initiatives developed by the ATP to increase the availability of state-of-the-art technologies to its investigators on all Indiana CTSI campuses, and the methods developed by the ATP to bridge the distance between campuses, technologies, and investigators for the advancement of clinical translational research. The methods and practices described in this publication may inform other approaches to enhance translational research, dissemination, and usage of innovative technologies by translational investigators, especially when distance or multi-campus cultural differences are factors to efficient application.
Identifiants
pubmed: 33948256
doi: 10.1017/cts.2020.525
pii: S2059866120005257
pmc: PMC8057440
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e33Informations de copyright
© The Association for Clinical and Translational Science 2020.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
J Struct Biol. 2017 Sep;199(3):225-236
pubmed: 28827185
Biopreserv Biobank. 2014 Dec;12(6):435-6
pubmed: 25496158
J Biomol Tech. 2015 Apr;26(1):1-3
pubmed: 25649473
Sci Transl Med. 2011 Aug 10;3(95):95cm21
pubmed: 21832235
EMBO Rep. 2016 Aug;17(8):1088-93
pubmed: 27412771
Clin Transl Sci. 2013 Aug;6(4):297-302
pubmed: 23919365
Nature. 2020 Feb;578(7794):201
pubmed: 32047310
Hum Gene Ther Methods. 2013 Feb;24(1):49-57
pubmed: 23360377
J Biomol Tech. 2016 Apr;27(1):25-39
pubmed: 26848284
J Biomol Tech. 2018 Sep;29(3):79-92
pubmed: 30140172